FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare

Free Newsletter

Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today!

About | Sample | Privacy
Related Topics >> Takeda | Moody's

Moody's gives Takeda top-notch rating

Tools

Moody's Investory Services gave a thumbs up to Takeda Pharmaceuticals, with an "Aa1" issuer rating, saying the company's outlook is stable and it is likely to remain strong financially following the its acquisition of Millennium Pharmaceuticals for $7.4 billion. Report

More stories about Takeda   Moody's  

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

What is 6 + 14?
To combat spam, please solve the math question above.